These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9095179)

  • 1. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470.
    Klauber N; Rohan RM; Flynn E; D'Amato RJ
    Nat Med; 1997 Apr; 3(4):443-6. PubMed ID: 9095179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro.
    Schoof DD; Obando JA; Cusack JC; Goedegebuure PS; Brem H; Eberlein TJ
    Int J Cancer; 1993 Oct; 55(4):630-5. PubMed ID: 7691763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate.
    Fraser HM; Dickson SE; Morris KD; Erickson GF; Lunn SF
    Hum Reprod; 1999 Aug; 14(8):2054-60. PubMed ID: 10438426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 5. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo.
    Takamiya Y; Brem H; Ojeifo J; Mineta T; Martuza RL
    Neurosurgery; 1994 May; 34(5):869-75; discussion 875. PubMed ID: 8052385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and action of angiogenic factors in the primate ovary.
    Stouffer RL; Martínez-Chequer JC; Molskness TA; Xu F; Hazzard TM
    Arch Med Res; 2001; 32(6):567-75. PubMed ID: 11750732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis in vivo by interleukin 12.
    Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
    J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis.
    Brem H; Gresser I; Grosfeld J; Folkman J
    J Pediatr Surg; 1993 Oct; 28(10):1253-7. PubMed ID: 7505321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
    Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
    J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470.
    O'Reilly MS; Brem H; Folkman J
    J Pediatr Surg; 1995 Feb; 30(2):325-9; discussion 329-30. PubMed ID: 7738759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis inhibition suppresses collagen arthritis.
    Peacock DJ; Banquerigo ML; Brahn E
    J Exp Med; 1992 Apr; 175(4):1135-8. PubMed ID: 1372645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis.
    Peacock DJ; Banquerigo ML; Brahn E
    Cell Immunol; 1995 Feb; 160(2):178-84. PubMed ID: 7536634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470.
    Berger AE; Dortch KA; Staite ND; Mitchell MA; Evans BR; Holm MS
    Agents Actions; 1993; 39 Spec No():C86-8. PubMed ID: 8273596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of experimental antiangiogenic therapy.
    Brem H; Folkman J
    J Pediatr Surg; 1993 Mar; 28(3):445-50; discussion 450-1. PubMed ID: 7682259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.
    McLeskey SW; Zhang L; Trock BJ; Kharbanda S; Liu Y; Gottardis MM; Lippman ME; Kern FG
    Br J Cancer; 1996 May; 73(9):1053-62. PubMed ID: 8624263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11.
    Maier JA; Delia D; Thorpe PE; Gasparini G
    Anticancer Drugs; 1997 Mar; 8(3):238-44. PubMed ID: 9095328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Osawa S; Terashima Y; Kimura G; Akimoto M
    BJU Int; 1999 Jan; 83(1):123-8. PubMed ID: 10233464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin4.5, induces fetal microphthalmia.
    Rutland CS; Jiang K; Soff GA; Mitchell CA
    Mol Vis; 2009 Jun; 15():1260-9. PubMed ID: 19572040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.